Anti-cancer and bactericidal activity of electrospun chitosan/poly(ethylene oxide)/papaya nanofibres
Electrospun nanofibers offer unique qualities, including a high surface-to-volume ratio, surface modification, and conversion to a fine mesh mat or membrane. Keeping this in mind, chitosan/polyethylene oxide (PEO)/papaya (Pap) nanofibers were developed by electrospinning and characterized by scannin...
Gespeichert in:
Veröffentlicht in: | Applied nanoscience 2023-09, Vol.13 (9), p.6105-6113 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Electrospun nanofibers offer unique qualities, including a high surface-to-volume ratio, surface modification, and conversion to a fine mesh mat or membrane. Keeping this in mind, chitosan/polyethylene oxide (PEO)/papaya (Pap) nanofibers were developed by electrospinning and characterized by scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR). The results from the study infers that, Ch:PEO:Pap (chitosan/PEO)/papaya) nanofibers had a diameter of 78.9 21 nm, resulting in a hydrophobic material with a high contact angle value. FTIR analysis confirms the existence of hydroxyl and amino groups during the interaction of chitosan/PEO and papaya. The Ch:PEO:Pap nanofiber inhibits bacterial growth in broth and the colony-forming ability of
Escherichia coli
(
E. coli
) and
Staphylococcus aureus
(
S. aureus
) strains. Furthermore, MDA-MB-231 breast cancer cells were found to be cytotoxic upon treatment with Ch:PEO:Pap nanofibers with an inhibitory half-maximum concentration of 60.37 ± 2.6 µg/mL. As indicated by fluorescence microscopy, Ch:PEO:Pap nanofibers stimulate apoptotic cell death by damaging the nuclear membrane. To summarize, the as-prepared Ch:PEO:Pap nanofiber can be a remarkable nanomaterial with an acceptable size that induces antibacterial and anticancer activity. |
---|---|
ISSN: | 2190-5509 2190-5517 |
DOI: | 10.1007/s13204-022-02669-2 |